Spots Global Cancer Trial Database for Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
Official Title: A Pilot Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
Study ID: NCT01679470
Conditions
Interventions
Study Description
Brief Summary: This is an open-label, single-center, single-dose efficacy pilot study of AuroLase Therapy in the treatment of subjects with primary and/or metastatic tumors of the lung where there is airway obstruction. In this study patients will be given a systemic IV infusion of particles and a subsequent escalating dose of laser radiation delivered by optical fiber via bronchoscopy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer Treatment Centers of America Eastern Regional Medical Center, Philadelphia, Pennsylvania, United States
Contact Details
Name: Glenn Goodrich, PhD
Affiliation: Nanospectra Biosciences
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
